FIELD: pharmaceutics.
SUBSTANCE: inventions relate to chemical-pharmaceutical industry and present a lyophilized liposome composition in gel phase for delivery of therapeutic and/or diagnostic agent, as well as a method for preparing the composition.
EFFECT: composition comprises an external cryoprotectant, with respect to said liposomes, and an internal, the concentration of which is less than 125 mM, and demonstrates excellent drug retention profiles and retains the size distribution after lyophilization and reproduction.
12 cl, 6 dwg, 6 tbl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| LYOPHILIZED LIPOSOMES | 2012 |
|
RU2780489C2 |
| METHOD OF LYOPHILIZED LIPOSOME PREPARING | 1997 |
|
RU2144352C1 |
| LIPOSOMAL PHARMACEUTICAL PREPARATION AND METHOD FOR PREPARING IT | 2007 |
|
RU2494729C2 |
| DISPOSABLE SYSTEM FOR STERILE OBTAINING OF LIPIDS AND NUCLEIC ACIDS PARTICLES | 2012 |
|
RU2642640C2 |
| LIPOSOMAL AGENT BASED ON UBIQUINOL AND PREPARATION METHOD THEREOF | 2015 |
|
RU2605616C1 |
| LIPOSOMAL COMPOSITION AND PREPARATION THEREOF | 2018 |
|
RU2728976C2 |
| LIPOSOMAL ANTITUMOR COMPOSITIONS | 2017 |
|
RU2756837C2 |
| LIPOSOMES CONTAINING PARTICLE MATERIALS | 1994 |
|
RU2145212C1 |
| DRIED RECONSTITUTED VESICLES FOR PHARMACEUTICAL APPLICATION | 2007 |
|
RU2443412C2 |
| LIPOSOME FORMULATION AND ITS PREPARATION | 2013 |
|
RU2649805C2 |
